Table of Contents
ISRN Analytical Chemistry
Volume 2012, Article ID 963276, 6 pages
http://dx.doi.org/10.5402/2012/963276
Research Article

Liquid Chromatographic Method for the Quantification of Antipsychotic Agent Iloperidone in Pharmaceutical Formulation

1Indukaka Ipcowala College of Pharmacy, Beyond GIDC Phase V, Vithal Udyognagar, New Vallabh Vidyanagar, Gujarat, Anand 388121, India
2Sun Pharmaceutical Industries Ltd, Formulation and Development Department, Baroda 390020, Gujarat, India

Received 14 December 2011; Accepted 9 January 2012

Academic Editor: T. Macko

Copyright © 2012 Usmangani K. Chhalotiya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Fanapt (Iloperidone) Tablets, Highlights of Prescribing Information (Revised 05/2009) and Full Prescribing Information, Vanda Pharmaceuticals Inc., Rockville, Md, USA, 2009.
  2. J. P. Kelleher, F. Centorrino, M. J. Albert, and R. J. Baldessarini, “Advances in atypical antipsychotics for the treatment of schizophrenia: new formulations and new agents,” CNS Drugs, vol. 16, no. 4, pp. 249–261, 2002. View at Google Scholar · View at Scopus
  3. A. E. Mutlib and J. T. Strupczewski, “Picogram determination of iloperidone in human plasma by solid-phase extraction and by high-performance liquid chromatography-selected-ion monitoring electrospray mass spectrometry,” Journal of Chromatography B, vol. 669, no. 2, pp. 237–246, 1995. View at Publisher · View at Google Scholar · View at Scopus
  4. S. M. Sainati, J. W. Hubbard, E. Chi, K. Grasing, and M. B. Brecher, “Safety, tolerability, and effect of food on the pharmacokinetics of iloperidone (HP 873), a potential atypical antipsychotic,” Journal of Clinical Pharmacology, vol. 35, no. 7, pp. 713–720, 1995. View at Google Scholar · View at Scopus
  5. A. E. Mutlib, J. T. Strupczewski, and S. M. Chesson, “Application of hyphenated LC/NMR and LC/MS techniques in rapid identification of in vitro and in vivo metabolites of iloperidone,” Drug Metabolism and Disposition, vol. 23, no. 9, pp. 951–964, 1995. View at Google Scholar · View at Scopus
  6. L. P. Mandpe and V. B. Pokharkar, “Stress degradation studies on Iloperidone and development of a stability indicating HPLC method for bulk drug and pharmaceutical dosage form,” Chimica Sinica, vol. 2, no. 2, pp. 230–239, 2011. View at Google Scholar
  7. International Conference on Harmonization, Q1B Photo stability Testing of New Drug Substances and Products International Conference on Harmonization, IFPMA, Geneva, Switzerland, 1996.
  8. International Conference on Harmonization, Q2 (R1) Validation of Analytical Procedure, Test and Methodology, International Conference on Harmonization, International Conference on Harmonization, Geneva, Switzerland, 2005.
  9. International Conference on Harmonization, Q2A Validation of Analytical Procedures: Consensus Guidelines, ICH Harmonized Tripartite Guidelines, 1994.
  10. International Conference on Harmonization, Q2B Validation of Analytical Procedures: Methodology, Consensus Guidelines, ICH Harmonized Tripartite Guidelines, 1996.
  11. International Conference on Harmonization, Q1A (R2) Stability Testing of New Drug Substances and Products International Conference on Harmonization, IFPMA, Geneva, Switzerland, 2003.